Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin E receptor 1 (EP1) is a G protein-coupled receptor that primarily binds prostaglandin E2 (PGE2). Upon activation by PGE2, it stimulates the phosphatidylinositol-calcium second messenger system, leading to increased intracellular calcium levels and subsequent cellular responses. It plays critical roles in pain perception, blood pressure regulation, renal function, and smooth muscle contraction. Targeting the EP1 receptor has been explored for managing conditions such as pain, hypertension, preterm labor, and certain cancers.
Gq protein activation; stimulation of phosphatidylinositol-calcium second messenger system; increased intracellular calcium levels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin E Receptor 1 (None).